BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20584001)

  • 21. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.
    Xu H; Strassmann G; Chan CC; Rizzo LV; Silver PB; Wiggert B; Caspi RR
    Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):942-50. PubMed ID: 10102291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Staphylococcal enterotoxin B is involved in aggravation and recurrence of murine experimental autoimmune uveoretinitis via Vbeta8+CD4+ T cells.
    Kohno H; Sakai T; Tsuneoka H; Imanishi K; Saito S
    Exp Eye Res; 2009 Oct; 89(4):486-93. PubMed ID: 19523946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blocking mast cell-mediated type I hypersensitivity in experimental allergic conjunctivitis by monocyte chemoattractant protein-1/CCR2.
    Tominaga T; Miyazaki D; Sasaki S; Mihara S; Komatsu N; Yakura K; Inoue Y
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5181-8. PubMed ID: 19553621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of the chemokines MIP-1alpha, MCP-1, and RANTES in experimental autoimmune uveitis.
    Crane IJ; McKillop-Smith S; Wallace CA; Lamont GR; Forrester JV
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1547-52. PubMed ID: 11381059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macrophages and dendritic cells in IRBP-induced experimental autoimmune uveoretinitis in B10RIII mice.
    Jiang HR; Lumsden L; Forrester JV
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3177-85. PubMed ID: 10586940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. WSX-1 plays a significant role for the initiation of experimental autoimmune uveitis.
    Sonoda KH; Yoshimura T; Takeda A; Ishibashi T; Hamano S; Yoshida H
    Int Immunol; 2007 Jan; 19(1):93-8. PubMed ID: 17118967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Collateral artery growth (arteriogenesis) after experimental arterial occlusion is impaired in mice lacking CC-chemokine receptor-2.
    Heil M; Ziegelhoeffer T; Wagner S; Fernández B; Helisch A; Martin S; Tribulova S; Kuziel WA; Bachmann G; Schaper W
    Circ Res; 2004 Mar; 94(5):671-7. PubMed ID: 14963007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Administration of a peptide inhibitor of alpha4-integrin inhibits the development of experimental autoimmune uveitis.
    Martín AP; de Moraes LV; Tadokoro CE; Commodaro AG; Urrets-Zavalia E; Rabinovich GA; Urrets-Zavalia J; Rizzo LV; Serra HM
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2056-63. PubMed ID: 15914623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of chemokine and receptors in Lewis rats with experimental autoimmune anterior uveitis.
    Fang IM; Yang CH; Lin CP; Yang CM; Chen MS
    Exp Eye Res; 2004 Jun; 78(6):1043-55. PubMed ID: 15109911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endogenous IL-12 is required for induction and expression of experimental autoimmune uveitis.
    Tarrant TK; Silver PB; Chan CC; Wiggert B; Caspi RR
    J Immunol; 1998 Jul; 161(1):122-7. PubMed ID: 9647215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contribution of CD4+CD25+ T cells to the regression phase of experimental autoimmune uveoretinitis.
    Sun M; Yang P; Du L; Zhou H; Ren X; Kijlstra A
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):383-9. PubMed ID: 19696173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential monocyte chemoattractant protein-1 and chemokine receptor 2 expression by murine lung fibroblasts derived from Th1- and Th2-type pulmonary granuloma models.
    Hogaboam CM; Bone-Larson CL; Lipinski S; Lukacs NW; Chensue SW; Strieter RM; Kunkel SL
    J Immunol; 1999 Aug; 163(4):2193-201. PubMed ID: 10438961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of CC chemokine receptor 2 in alveolar monocyte and neutrophil immigration in intact mice.
    Maus U; von Grote K; Kuziel WA; Mack M; Miller EJ; Cihak J; Stangassinger M; Maus R; Schlöndorff D; Seeger W; Lohmeyer J
    Am J Respir Crit Care Med; 2002 Aug; 166(3):268-73. PubMed ID: 12153956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of CC chemokine receptor 2 on microglia activation and blood-borne cell recruitment after transient focal cerebral ischemia in mice.
    Schilling M; Strecker JK; Ringelstein EB; Schäbitz WR; Kiefer R
    Brain Res; 2009 Sep; 1289():79-84. PubMed ID: 19559679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dynamics of leukocyte infiltration in experimental autoimmune uveoretinitis.
    Kerr EC; Copland DA; Dick AD; Nicholson LB
    Prog Retin Eye Res; 2008 Sep; 27(5):527-35. PubMed ID: 18723108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental autoimmune uveoretinitis initiated by non-phagocytic destruction of inner segments of photoreceptor cells by Mac-1(+) mononuclear cells.
    Miura-Takeda S; Tashiro-Yamaji J; Oku H; Takahashi T; Shimizu T; Sugiyama T; Ikeda T; Kubota T; Yoshida R
    Microbiol Immunol; 2008 Dec; 52(12):601-10. PubMed ID: 19120974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy.
    Göser S; Ottl R; Brodner A; Dengler TJ; Torzewski J; Egashira K; Rose NR; Katus HA; Kaya Z
    Circulation; 2005 Nov; 112(22):3400-7. PubMed ID: 16316965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation.
    Oh K; Byoun OJ; Ham DI; Kim YS; Lee DS
    Eur J Immunol; 2011 Feb; 41(2):392-402. PubMed ID: 21268009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological profile of JNJ-27141491 [(S)-3-[3,4-difluorophenyl)-propyl]-5-isoxazol-5-yl-2-thioxo-2,3-dihydro-1H-imidazole-4-carboxyl acid methyl ester], as a noncompetitive and orally active antagonist of the human chemokine receptor CCR2.
    Buntinx M; Hermans B; Goossens J; Moechars D; Gilissen RA; Doyon J; Boeckx S; Coesemans E; Van Lommen G; Van Wauwe JP
    J Pharmacol Exp Ther; 2008 Oct; 327(1):1-9. PubMed ID: 18599682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of experimental ocular inflammation on ocular immune privilege.
    Ohta K; Wiggert B; Taylor AW; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2010-8. PubMed ID: 10440255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.